INmune Bio, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 989,558 | $4.62 M | 5.33% | 4.90% |
| PRAETORIAN PR LLC | 02/14/2025 | 812,210 | $3.79 M | 4.02% | 4.02% |
| VANGUARD GROUP INC | 02/11/2025 | 738,201 | $3.45 M | 2.43% | 3.66% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 475,551 | $2.22 M | 100.00% | 2.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 363,602 | $1.70 M | 5.56% | 1.80% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 291,327 | $1.36 M | 43.86% | 1.44% |
| STATE STREET CORP | 02/14/2025 | 226,428 | $1.06 M | 0.00% | 1.12% |
| 02/14/2025 | 191,822 | $895,809 | 100.00% | 0.95% | |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 185,800 | $867,686 | 73.32% | 0.92% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 178,284 | $832,586 | 0.00% | 0.88% |
| MORGAN STANLEY | 02/14/2025 | 155,126 | $724,439 | 68.35% | 0.77% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 139,800 | $652,866 | -34.49% | 0.69% |
| UBS GROUP AG | 02/14/2025 | 136,248 | $636,278 | 215.71% | 0.68% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 109,848 | $512,990 | 0.00% | 0.54% |
| NORTHERN TRUST CORP | 02/14/2025 | 105,961 | $494,838 | 9.46% | 0.52% |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 100,767 | $470,582 | -37.32% | 0.50% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 01/17/2025 | 89,975 | $420,191 | 26.17% | 0.45% |
| PEKIN HARDY STRAUSS, INC. | 02/04/2025 | 83,350 | $389,244 | 100.00% | 0.41% |
| MARSHALL WACE, LLP | 02/13/2025 | 77,468 | $361,776 | -3.03% | 0.38% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 66,384 | $310,013 | 444.85% | 0.33% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 63,615 | $297,082 | 92.72% | 0.32% |
| CITADEL ADVISORS LLC | 02/14/2025 | 62,500 | $291,875 | 113.31% | 0.31% |
| XTX TOPCO LTD | 02/13/2025 | 61,271 | $286,136 | 32.47% | 0.30% |
| CITADEL ADVISORS LLC | 02/14/2025 | 52,197 | $243,760 | 13.19% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 50,402 | $235,377 | 1.72% | 0.25% |
| FERMATA ADVISORS, LLC | 01/15/2025 | 46,997 | $219,476 | 9.99% | 0.23% |
| DIAMETRIC CAPITAL, LP | 02/12/2025 | 36,699 | $171,384 | 24.59% | 0.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 34,666 | $161,890 | 1.99% | 0.17% |
| LAIRD NORTON TRUST COMPANY, LLC | 02/14/2025 | 34,100 | $159,247 | 3.81% | 0.17% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 33,719 | $157,468 | 100.00% | 0.17% |
| BARCLAYS PLC | 02/13/2025 | 32,019 | $150,000 | 10.24% | 0.16% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 30,449 | $142,196 | 15.19% | 0.15% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 25,513 | $119,146 | 799.93% | 0.13% |
| HSBC HOLDINGS PLC | 02/14/2025 | 25,211 | $118,996 | 34.17% | 0.12% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 25,139 | $117,399 | 71.62% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 25,100 | $117,217 | 100.00% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 23,495 | $109,722 | 100.00% | 0.12% |
| ROYAL BANK OF CANADA | 02/14/2025 | 20,627 | $96,000 | -66.78% | 0.10% |
| LPL FINANCIAL LLC | 02/11/2025 | 19,072 | $89,066 | 32.98% | 0.09% |
| CITADEL ADVISORS LLC | 02/14/2025 | 17,800 | $83,126 | -61.64% | 0.09% |
| RHUMBLINE ADVISERS | 01/30/2025 | 16,744 | $78,188 | 16.93% | 0.08% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 16,518 | $77,139 | 0.00% | 0.08% |
| FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 01/27/2025 | 15,500 | $72,385 | 14.81% | 0.08% |
| MARINER, LLC | 02/13/2025 | 13,836 | $64,614 | 100.00% | 0.07% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 13,298 | $62,102 | 100.00% | 0.07% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 12,700 | $59,309 | 100.00% | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 12,406 | $57,936 | 15.65% | 0.06% |
| JPMORGAN CHASE & CO | 02/12/2025 | 11,335 | $52,935 | 92.97% | 0.06% |
| CITIGROUP INC | 02/12/2025 | 10,831 | $50,581 | 11.01% | 0.05% |
| BEACON POINTE ADVISORS, LLC | 02/14/2025 | 10,368 | $48,419 | 100.00% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
INmune Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of INmune Bio, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 989,558
Praetorian PR LLC: 812,210
VANGUARD GROUP INC: 738,201
RAYMOND JAMES FINANCIAL INC: 475,551
GEODE CAPITAL MANAGEMENT, LLC: 363,602
MILLENNIUM MANAGEMENT LLC: 291,327
30.57% of INmune Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.85 M shares in the last 24 months. This purchase volume represents approximately $56.69 M in transactions.